The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)

NCT02331472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-07-05

No results posted yet for this study

Summary

This study is to evaluate the efficacy of urine biomarker in patients with interstitial cystitis/painful bladder syndrome

Conditions

  • Chronic Interstitial Cystitis

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Myung-Soo Choo, MD, PhD · Asan Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-03
Primary Completion
2016-01-14
Completion
2016-01-14

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331472 on ClinicalTrials.gov